glp 1 anti inflammatory effects Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits Central glucagon-like peptide 1 receptor

Together, these findings highlight the early but promising role of GLP-1 therapies in addressing both obesity and maladaptive reward-driven behaviors, as the clinical landscape continues to evolve

Furthermore, CVOTs have documented the cardiovascular safety of the GLP-1 RA drug class in type 2 diabetes (Sattar et al., 2021)

Oncology drugs continue to be a major cost driver, with double-digit spending growth due to expensive new therapies and expanded treatments

Episode Overview: (0:00) Intro/Teaser (7:00) How a Parasite Became a Perimenopause Wake-Up Call (11:00) Why Women Resist the Word Perimenopause (16:00) The Gut-Hormone Connection Nobodys Talking About (21:00) The Medical System Was Never Built for Middle-Aged Women (30:00) Body Composition, the Scale, and the Comments That Stick (34:00) The ACE Study: How Childhood Trauma Rewires the Gut and Immune System (41:00) Oral Contraceptives, Antibiotics, and the Developing Microbiome (48:00) The Estrobolome (53:00) The 612 Window (56:00) Sleep, Stress, and Nutrition The Three Biggest Levers in Perimenopause (1:02:00) Advice for Mothers of Daughters (1:05:00) Cynthias Personal Daily Protocol (1:13:00) The Menopause Gut: Elevator Pitch and Where to Find It (1:15:00) After Party Dr

Unlike medications that target only one pathway, tirzepatide injections work through two hormonal systems, reducing appetite, enhancing insulin sensitivity, and potentially increasing calorie burning

Prior authorization is required for GLP-1 medications to ensure that they are medically necessary and that the insurance company is covering treatments that align with their approved guidelines